Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Stéphanie Desmedt, Valérie Desmedt, Leen De Vos, Joris R. Delanghe, Reinhart Speeckaert & Marijn M. Speeckaert. (2019) Growth differentiation factor 15: A novel biomarker with high clinical potential. Critical Reviews in Clinical Laboratory Sciences 56:5, pages 333-350.
Read now
Read now
Huijuan Kou, Xin Jin, Dengfeng Gao, Rui Ma, Xin Dong, Jin Wei & Xin Wang. (2018) Association between growth differentiation factor 15 and left ventricular hypertrophy in hypertensive patients and healthy adults. Clinical and Experimental Hypertension 40:1, pages 8-15.
Read now
Read now
Gerasimos Siasos, Dimitris Tousoulis, Evangelos Oikonomou, Eleni Kokkou, Savvas Mazaris, Theodosia Konsola & Christodoulos Stefanadis. (2014) Novel biomarkers in heart failure: usefulness in clinical practice. Expert Review of Cardiovascular Therapy 12:3, pages 311-321.
Read now
Read now
Xinye Xu, Zijian Li & Wei Gao. (2011) Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside. Biomarkers 16:6, pages 466-475.
Read now
Read now
Frank Kramer & Hendrik Milting. (2011) Novel biomarkers in human terminal heart failure and under mechanical circulatory support. Biomarkers 16:sup1, pages S31-S41.
Read now
Read now
Articles from other publishers (20)
Bianca Olivia Cojan-Minzat, Alexandru Zlibut & Lucia Agoston-Coldea. (2020) Non-ischemic dilated cardiomyopathy and cardiac fibrosis. Heart Failure Reviews 26:5, pages 1081-1101.
Crossref
Crossref
Luc Rochette, Geoffrey Dogon, Marianne Zeller, Yves Cottin & Catherine Vergely. (2021) GDF15 and Cardiac Cells: Current Concepts and New Insights. International Journal of Molecular Sciences 22:16, pages 8889.
Crossref
Crossref
Frank Kramer, Javed Butler, Sanjiv J. Shah, Christian Jung, Savina Nodari, Stephan Rosenkranz, Michele Senni, Luke Bamber, Stephan Cichos, Chrysanthi Dori, Toeresin Karakoyun, Gabriele Jenny Köhler, Kinjal Patel, Paolo Piraino, Thomas Viethen, Praneeth Chennuru, Ayse Paydar, Jason Sims, Richard Clark, Rob van Lummel, Alexandra Müller, Chad Gwaltney, Salko Smajlovic, Hans-Dirk Düngen & Wilfried Dinh. (2020) Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure Trials. Digital Biomarkers 4:2, pages 45-59.
Crossref
Crossref
Liu Zhu, Chao Li, Qiang Liu, Weiting Xu & Xiang Zhou. (2019) Molecular biomarkers in cardiac hypertrophy. Journal of Cellular and Molecular Medicine 23:3, pages 1671-1677.
Crossref
Crossref
O. O. Mikheeva, S. P. Domogatsky, E. E. Efremov & R. S. Esipov. (2018) Molecular markers for diagnostics of cardiac failure. Kardiologicheskii vestnik 13:4, pages 62.
Crossref
Crossref
E.S. Shao. 2018. Encyclopedia of Cardiovascular Research and Medicine. Encyclopedia of Cardiovascular Research and Medicine
453
463
.
E.S. Shao. 2017. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Umesh Chaudhari, Harshal Nemade, Vilas Wagh, John Antonydas Gaspar, James K. Ellis, Sureshkumar Perumal Srinivasan, Dimitry Spitkovski, Filomain Nguemo, Jochem Louisse, Susanne Bremer, Jürgen Hescheler, Hector C. Keun, Jan G. Hengstler & Agapios Sachinidis. (2015) Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment. Archives of Toxicology 90:11, pages 2763-2777.
Crossref
Crossref
Frank Kramer & Wilfried Dinh. (2016) Molecular and Digital Biomarker Supported Decision Making in Clinical Studies in Cardiovascular Indications. Archiv der Pharmazie 349:6, pages 399-409.
Crossref
Crossref
Ji Min KimMin Kyung BackHyon-Seung YiKyong Hye JoungHyun Jin Kim & Bon Jeong Ku. (2016) Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia. Diabetes & Metabolism Journal 40:1, pages 70.
Crossref
Crossref
Gad Cotter, Adriaan A. Voors, Margaret F. Prescott, G. Michael Felker, Gerasimos Filippatos, Barry H. Greenberg, Peter S. Pang, Piotr Ponikowski, Olga Milo, Tsushung A. Hua, Min Qian, Thomas M. Severin, John R. Teerlink, Marco Metra & Beth A. Davison. (2015) Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study. European Journal of Heart Failure 17:11, pages 1133-1143.
Crossref
Crossref
Xiang-Yang Li, Jiang Ying, Jiu-Hong Li, Sheng-Lang Zhu, Jiang Li & Pearl Pai. (2014) Growth differentiation factor GDF-15 does not influence iron metabolism in stable chronic haemodialysis patients. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 52:3, pages 399-403.
Crossref
Crossref
Goran Loncar, Daniel Omersa, Natasa Cvetinovic, Aleksandra Arandjelovic & Mitja Lainscak. (2014) Emerging Biomarkers in Heart Failure and Cardiac Cachexia. International Journal of Molecular Sciences 15:12, pages 23878-23896.
Crossref
Crossref
Jeng-Feng Lin, Semon Wu, Shun-Yi Hsu, Kuan-Hung Yeh, Hsin-Hua Chou, Shih-Tsung Cheng, Tien-Yu Wu, Wen-Tze Hsu, Chun-Chun Yang & Yu-Lin Ko. (2014) Growth-Differentiation Factor-15 and Major Cardiac Events. The American Journal of the Medical Sciences 347:4, pages 305-311.
Crossref
Crossref
Xin-ye Xu, Ying Nie, Fang-fang Wang, Yan Bai, Zhi-zhen Lv, You-yi Zhang, Zi-jian Li & Wei Gao. (2014) Growth Differentiation Factor (GDF)-15 Blocks Norepinephrine-induced Myocardial Hypertrophy via a Novel Pathway Involving Inhibition of Epidermal Growth Factor Receptor Transactivation. Journal of Biological Chemistry 289:14, pages 10084-10094.
Crossref
Crossref
David W. Schopfer, Ivy A. Ku, Mathilda Regan & Mary A. Whooley. (2014) Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study). American Heart Journal 167:2, pages 186-192.e1.
Crossref
Crossref
Rajalakshmi Santhanakrishnan, Jenny P.C. Chong, Tze P. Ng, Lieng H. Ling, David Sim, Kui Toh G. Leong, Poh Shuan D. Yeo, Hean Y. Ong, Fazlur Jaufeerally, Raymond Wong, Ping Chai, Adrian F. Low, Arthur Mark Richards & Carolyn S.P. Lam. (2014) Growth differentiation factor 15, ST2, high‐sensitivity troponin T, and N‐terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction. European Journal of Heart Failure 14:12, pages 1338-1347.
Crossref
Crossref
P Vaňhara, A Hampl, A Kozubík & K Souček. (2012) Growth/differentiation factor-15: prostate cancer suppressor or promoter?. Prostate Cancer and Prostatic Diseases 15:4, pages 320-328.
Crossref
Crossref
Sjoukje I. Lok, Bjorn Winkens, Roel Goldschmeding, Ankie J.P. van Geffen, Fay M.A. Nous, Joyce van Kuik, Petra van der Weide, Corinne Klöpping, J. Hans Kirkels, Jaap R. Lahpor, Pieter A. Doevendans, Nicolaas de Jonge & Roel A. de Weger. (2014) Circulating growth differentiation factor‐15 correlates with myocardial fibrosis in patients with non‐ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support. European Journal of Heart Failure 14:11, pages 1249-1256.
Crossref
Crossref
Christian Stratz, Michael Amann, David D. Berg, David A. Morrow, Franz-Josef Neumann & Willibald Hochholzer. (2012) Novel Biomarkers in Cardiovascular Disease. Cardiology in Review 20:3, pages 111-117.
Crossref
Crossref